Triple Antibiotic Plus Pain Relief
- Product NDC
- 42507-679
- 11-digit product format
- 425070679
- Labeler code
- 42507
- Product ID
- 42507-679_a0f2663d-acb6-4828-93b4-74f3423a13ae
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- HyVee Inc
- Application
- M004
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2015-09-27
- Substance
- BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE
- Active strength
- 500; 3.5; 10000; 10 [USP'U]/g; mg/g; [USP'U]/g; mg/g
- Pharmacologic classes
- Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 42507-679-64 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 42507-679-64 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 42507-679-64 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 42507-679-64 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 42507-679-64 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 42507-679-64 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 42507-679-64 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 42507-679-64 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 42507-679-64 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 42507-679-64 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 42507-679-64 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 42507-679-64 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Triple Antibiotic Plus Pain Relief
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BACITRACIN ZINC | 500 [USP'U]/g |
| NEOMYCIN SULFATE | 3.5 mg/g |
| POLYMYXIN B SULFATE | 10000 [USP'U]/g |
| PRAMOXINE HYDROCHLORIDE | 10 mg/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 89Y4M234ES | Internal UNII lookup |
| 057Y626693 | Internal UNII lookup |
| 19371312D4 | Internal UNII lookup |
| 88AYB867L5 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1359350 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 69a4b642-b7ec-43cc-aa57-6858da0b3d63 | Available on FDA.report |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Major Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B SULFAT | Major Pharmaceuticals | a6cc3fbc-6302-4033-e053-2a95a90a19f0 | 2024-09-11 | Warnings | M004 |
| Leader Triple antibiotic | BACITRACIN,NEOMYCIN,POLYMXIN | Cardinal Health 110 dba LEADER | 2175e00a-bf85-3377-e063-6394a90a916f | 2024-09-06 | Warnings | M004 |
| Members Mark Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | Sam's West Inc | 200f4020-7699-4a9e-8fab-2d3df9e76836 | 2024-09-05 | Warnings | M004 |
| Leader Poly Bacitracin | BACITRACIN ZINC POLYMIXIN B SULFATE | Cardinal Health 110 dba LEADER | 20d7624f-cafa-25e1-e063-6394a90a4439 | 2024-08-29 | Warnings | M004 |
| triple antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | Meijer Distribution Inc | edcb423e-b5c2-4e26-8f7f-9b9ee575042c | 2024-08-19 | Warnings | M004 |
| Major Clotrimazole | CLOTRIMAZOLE | NuCare Pharmaceuticals,Inc. | 562dfc9f-1897-330a-e054-00144ff8d46c | 2024-08-14 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Wildeman Business Group | 1f96450a-3bda-1f0a-e063-6294a90a514f | 2024-08-13 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Provision Medical | bbf4b99c-9738-4855-82a6-f4e213924ec9 | 2024-08-09 | Warnings | M004 |
| Tetracyte Topical Tetracycline Hydrochloride | TETRACYCLINE HYDROCHLORIDE | VIADERMA DISTRIBUTION INC | 4ac5177d-bb67-45e6-adcf-44f0821746bd | 2024-08-01 | Warnings | M004 |
| Bacitracin | BACITRACIN | Padagis Israel Pharmaceuticals Ltd | bebbedf6-dd65-47a4-aa3e-ad197b3e05a1 | 2024-07-31 | Warnings | M004 |
| Bacitracin Zinc | BACITRACIN ZINC | Chain Drug Marketing Association Inc. | 1cd9ded3-068c-496e-e063-6394a90a6a0b | 2024-07-09 | Warnings | M004 |
| Anti-Itch with Aloe | HYDROCORTISONE 1% | Chain Drug Marketing Association Inc. | 1cbea7cd-03a0-1469-e063-6294a90a7cc1 | 2024-07-08 | Warnings | M004 |
| astonea First Aid | BACITRACIN ZINC | ASTONEA LABS PRIVATE LIMITED | de0b2e06-64bc-78f0-e053-2995a90a39a0 | 2024-06-25 | Warnings | M004 |
| Publix Bacitracin Zinc | BACITRACIN ZINC | PUBLIX SUPER MARKETS, INC. | 51f21123-7826-40c9-b2aa-b202125085e2 | 2024-06-17 | Warnings | M004 |
| Publix Triple Antibiotic | BACITRACIN ZINC 400 U, POLYMXYIN B SULFATE 5,000 U, NEOMYCIN SULFATE 3.5MG/G | PUBLIX SUPER MARKETS, INC. | 871fa43c-a1be-4c15-bbfa-a998a2d89d2e | 2024-06-17 | Warnings | M004 |
| Biofreeze Professional | MENTHOL, UNSPECIFIED FORM | NuCare Pharmaceuticals,Inc. | 66ff9726-20da-688a-e053-2a91aa0a59ac | 2024-06-06 | Warnings | M004 |
| QC Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE. | Chain Drug Marketing Association | 1a1501a4-75b0-5900-e063-6394a90ad77a | 2024-06-04 | Warnings | M004 |
| Always Save Bacitracin Zinc | BACITRACIN ZINC | Trifecta Pharmaceuticals USA LLC | 1a00df31-a38a-fc82-e063-6394a90abbf3 | 2024-06-03 | Warnings | M004 |
| PENTREXCILINA TRIPLE ANTIBIOTIC PLUS PAIN RELIEF | BACITRACIN, NEOMYCIN, POLYMYXIN B, PRAMOXINE | OPMX LLC | 7c0d3cdf-af50-4a65-a01b-a33510feeb94 | 2024-05-17 | Warnings | M004 |
| PENIMIXCINA | BACITRACIN, NEOMYCIN SULFATE, POLYMIXIN B SULFATE, PRAMOXINE HYDROCHLORIDE | OPMX LLC | 92bcbc02-9683-4117-af2b-6d4687796f1f | 2024-05-17 | Warnings | M004 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 42507-679-64 | 42507067964 | 1 TUBE in 1 CARTON (42507-679-64) / 28 g in 1 TUBE (42507-679-28) | 1 tube | 2015-09-27 | No | No | Current |